DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis
Europe - FRA:DRW8 - DE0005550602 - Common Stock
53 EUR
-1.6 (-2.93%)
Overall DRW8 gets a fundamental rating of 5 out of 10. We evaluated DRW8 against 59 industry peers in the Health Care Equipment & Supplies industry. DRW8 has only an average score on both its financial health and profitability. DRW8 is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DRW8 had positive earnings in the past year.
DRW8 had a positive operating cash flow in the past year.
DRW8 had positive earnings in 4 of the past 5 years.
DRW8 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.34%, DRW8 is in line with its industry, outperforming 52.54% of the companies in the same industry.
The Return On Equity of DRW8 (6.82%) is better than 61.02% of its industry peers.
DRW8's Return On Invested Capital of 6.55% is fine compared to the rest of the industry. DRW8 outperforms 66.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.34% | ||
| ROE | 6.82% | ||
| ROIC | 6.55% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DRW8's Profit Margin of 2.97% is in line compared to the rest of the industry. DRW8 outperforms 49.15% of its industry peers.
In the last couple of years the Profit Margin of DRW8 has grown nicely.
With a Operating Margin value of 5.13%, DRW8 is not doing good in the industry: 61.02% of the companies in the same industry are doing better.
DRW8's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 44.86%, DRW8 is doing worse than 61.02% of the companies in the same industry.
DRW8's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.13% | ||
| PM (TTM) | 2.97% | ||
| GM | 44.86% |
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
2. Health
2.1 Basic Checks
DRW8 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, DRW8 has less shares outstanding
DRW8 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DRW8 has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.56 indicates that DRW8 is not a great score, but indicates only limited risk for bankruptcy at the moment.
DRW8 has a Altman-Z score (2.56) which is comparable to the rest of the industry.
DRW8 has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as DRW8 would need 3.51 years to pay back of all of its debts.
DRW8 has a better Debt to FCF ratio (3.51) than 76.27% of its industry peers.
DRW8 has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
DRW8's Debt to Equity ratio of 0.16 is fine compared to the rest of the industry. DRW8 outperforms 76.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 2.56 |
ROIC/WACC1.04
WACC6.31%
2.3 Liquidity
A Current Ratio of 1.74 indicates that DRW8 should not have too much problems paying its short term obligations.
The Current ratio of DRW8 (1.74) is comparable to the rest of the industry.
A Quick Ratio of 1.03 indicates that DRW8 should not have too much problems paying its short term obligations.
DRW8 has a Quick ratio (1.03) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
The earnings per share for DRW8 have decreased strongly by -14.12% in the last year.
DRW8 shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 36.42% yearly.
The Revenue has decreased by -0.03% in the past year.
The Revenue has been growing slightly by 3.92% on average over the past years.
EPS 1Y (TTM)-14.12%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%-57.73%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%-0.6%
3.2 Future
DRW8 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.39% yearly.
The Revenue is expected to grow by 2.84% on average over the next years.
EPS Next Y2.83%
EPS Next 2Y10.4%
EPS Next 3Y12.28%
EPS Next 5Y6.39%
Revenue Next Year2.76%
Revenue Next 2Y3.42%
Revenue Next 3Y3.63%
Revenue Next 5Y2.84%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
DRW8 is valuated reasonably with a Price/Earnings ratio of 9.94.
Compared to the rest of the industry, the Price/Earnings ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 98.31% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.38, DRW8 is valued rather cheaply.
A Price/Forward Earnings ratio of 7.31 indicates a rather cheap valuation of DRW8.
96.61% of the companies in the same industry are more expensive than DRW8, based on the Price/Forward Earnings ratio.
DRW8 is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.94 | ||
| Fwd PE | 7.31 |
4.2 Price Multiples
DRW8's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DRW8 is cheaper than 91.53% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DRW8 is valued cheaper than 96.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.8 | ||
| EV/EBITDA | 3.8 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as DRW8's earnings are expected to grow with 12.28% in the coming years.
PEG (NY)3.51
PEG (5Y)0.27
EPS Next 2Y10.4%
EPS Next 3Y12.28%
5. Dividend
5.1 Amount
DRW8 has a Yearly Dividend Yield of 3.46%.
Compared to an average industry Dividend Yield of 2.30, DRW8 pays a better dividend. On top of this DRW8 pays more dividend than 93.22% of the companies listed in the same industry.
DRW8's Dividend Yield is a higher than the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.46% |
5.2 History
On average, the dividend of DRW8 grows each year by 51.02%, which is quite nice.
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
5.3 Sustainability
DRW8 pays out 37.52% of its income as dividend. This is a sustainable payout ratio.
DRW8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP37.52%
EPS Next 2Y10.4%
EPS Next 3Y12.28%
FRA:DRW8 (9/19/2025, 7:00:00 PM)
53
-1.6 (-2.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners9.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap994.28M
Analysts77.14
Price Target74.01 (39.64%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.46% |
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP37.52%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.87%
PT rev (3m)5.15%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2%
EPS NY rev (3m)2%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)-1.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.94 | ||
| Fwd PE | 7.31 | ||
| P/S | 0.3 | ||
| P/FCF | 7.8 | ||
| P/OCF | 5.22 | ||
| P/B | 0.68 | ||
| P/tB | 0.88 | ||
| EV/EBITDA | 3.8 |
EPS(TTM)5.33
EY10.06%
EPS(NY)7.25
Fwd EY13.67%
FCF(TTM)6.79
FCFY12.82%
OCF(TTM)10.16
OCFY19.17%
SpS179.14
BVpS78.08
TBVpS59.93
PEG (NY)3.51
PEG (5Y)0.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.34% | ||
| ROE | 6.82% | ||
| ROCE | 8.71% | ||
| ROIC | 6.55% | ||
| ROICexc | 7.37% | ||
| ROICexgc | 9.14% | ||
| OM | 5.13% | ||
| PM (TTM) | 2.97% | ||
| GM | 44.86% | ||
| FCFM | 3.79% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-18.01%
ROICexcg growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score6
Asset Turnover1.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 0.73 | ||
| Cap/Depr | 43.12% | ||
| Cap/Sales | 1.88% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 59.79% | ||
| Profit Quality | 127.61% | ||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.56 |
F-Score6
WACC6.31%
ROIC/WACC1.04
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.12%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%-57.73%
EPS Next Y2.83%
EPS Next 2Y10.4%
EPS Next 3Y12.28%
EPS Next 5Y6.39%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%-0.6%
Revenue Next Year2.76%
Revenue Next 2Y3.42%
Revenue Next 3Y3.63%
Revenue Next 5Y2.84%
EBIT growth 1Y-8.68%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year81.53%
EBIT Next 3Y29.41%
EBIT Next 5Y12.32%
FCF growth 1Y1126.25%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y201.26%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%